Identification of RANKL in osteolytic lesions of the facial skeleton.
about
Host response mechanisms in periodontal diseasesCombined effect of bisphosphonate and recombinant human bone morphogenetic protein 2 on bone healing of rat calvarial defectsTopical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats.Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation.Biochemical markers as predictors of bone remodelling in dental disorders: a narrative description of literatureDifferential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions.Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease.An insight into the regulatory mechanisms of cells involved in resorption of dental hard tissuesThe regulation of bone turnover in ameloblastoma using an organotypic in vitro co-culture model.TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblastsIncreased levels of the T-helper 22-associated cytokine (interleukin-22) and transcription factor (aryl hydrocarbon receptor) in patients with periodontitis are associated with osteoclast resorptive activity and severity of the disease.High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes.Comparison of osteoclastogenesis and local invasiveness of ameloblastoma and keratocystic odontogenic tumor.Immunohistochemical and mRNA expression of RANK, RANKL, OPG, TLR2 and MyD88 during apical periodontitis progression in mice.
P2860
Q26801846-71770DF8-437C-4631-9A58-3427B99715E5Q35808015-46B5CF2C-4EC4-488F-99F6-E2F92AF99BC3Q35999787-65C797D4-1C30-4889-B971-CE2C0B134373Q36296474-775D80E7-5F79-4F42-8B5A-3C516E8C8E0FQ36333489-650BBBA4-81A7-46C3-8C73-AF8E16E9032AQ37286024-3E649296-EDF0-4CF0-BBE8-873E85D0C9A1Q37705912-EE9D65B9-5A55-40BE-BD02-C887F9EE2B8EQ38035357-EA7AAF81-DEF4-4D63-A3B3-17BBC651CA93Q38163969-4F4980E9-C30F-4E52-93F4-77521E98D971Q41268590-AA4CB3EC-396A-4707-81D3-D723733F087AQ42532851-BCFFDD31-564F-4292-AB8C-F0BF52BEA473Q48298831-73360FDB-2A7E-4FF5-A206-7D155ACA8BB8Q54577133-CDFC38B8-F018-4B7C-9E37-D0BF5DD991C9Q55094310-5A02212A-DB23-42FB-B80D-0496A1E4085FQ55435478-87ED7BF8-0FCA-454B-85B3-9DCA17A45B59
P2860
Identification of RANKL in osteolytic lesions of the facial skeleton.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Identification of RANKL in osteolytic lesions of the facial skeleton.
@en
Identification of RANKL in osteolytic lesions of the facial skeleton.
@nl
type
label
Identification of RANKL in osteolytic lesions of the facial skeleton.
@en
Identification of RANKL in osteolytic lesions of the facial skeleton.
@nl
prefLabel
Identification of RANKL in osteolytic lesions of the facial skeleton.
@en
Identification of RANKL in osteolytic lesions of the facial skeleton.
@nl
P2093
P2860
P1476
Identification of RANKL in osteolytic lesions of the facial skeleton
@en
P2093
P2860
P304
P356
10.1177/154405910408300415
P407
P50
P577
2004-04-01T00:00:00Z